Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Gene | RET |
Variant | G810S |
Impact List | missense |
Protein Effect | unknown |
Gene Variant Descriptions | RET G810S lies within the protein kinase domain of the Ret protein (UniProt.org). G810S has been demonstrated to confer resistance to tyrosine kinase inhibitors in the context of RET fusions (PMID: 29908090, PMID: 31988000, PMID: 36996322), but has not been biochemically characterized and therefore, its effect on Ret protein function is unknown (PubMed, Aug 2024). |
Associated Drug Resistance | Y |
Category Variants Paths |
RET mutant RET G810S |
Transcript | NM_020975.6 |
gDNA | chr10:g.43119566G>A |
cDNA | c.2428G>A |
Protein | p.G810S |
Source Database | RefSeq |
Genome Build | GRCh38/hg38 |
Transcript | gDNA | cDNA | Protein | Source Database | Genome Build |
---|---|---|---|---|---|
NM_001406744.1 | chr10:g.43119566G>A | c.2428G>A | p.G810S | RefSeq | GRCh38/hg38 |
NM_001406759.1 | chr10:g.43119566G>A | c.2428G>A | p.G810S | RefSeq | GRCh38/hg38 |
NM_001406743.1 | chr10:g.43119566G>A | c.2428G>A | p.G810S | RefSeq | GRCh38/hg38 |
NM_001406760.1 | chr10:g.43119566G>A | c.2428G>A | p.G810S | RefSeq | GRCh38/hg38 |
NM_020975.5 | chr10:g.43119566G>A | c.2428G>A | p.G810S | RefSeq | GRCh38/hg38 |
NM_020975.6 | chr10:g.43119566G>A | c.2428G>A | p.G810S | RefSeq | GRCh38/hg38 |
NM_020630.5 | chr10:g.43119566G>A | c.2428G>A | p.G810S | RefSeq | GRCh38/hg38 |
NM_020975 | chr10:g.43119566G>A | c.2428G>A | p.G810S | RefSeq | GRCh38/hg38 |
NM_020630.7 | chr10:g.43119566G>A | c.2428G>A | p.G810S | RefSeq | GRCh38/hg38 |
NM_020630 | chr10:g.43119566G>A | c.2428G>A | p.G810S | RefSeq | GRCh38/hg38 |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|---|---|---|---|---|---|---|
RET G810S | Advanced Solid Tumor | predicted - sensitive | TPX-0046 | Preclinical - Cell culture | Actionable | In a preclinical study, TPX-0046 treatment led to inhibition of cell proliferation in a transformed cell line expressing RET G810S in culture (J Clin Oncol 38, no. 15_suppl (May 20, 2020) 3616-3616). | detail... |
RET G810S | Advanced Solid Tumor | predicted - sensitive | APS03118 | Preclinical - Cell culture | Actionable | In a preclinical study, APS03118 inhibited the enzymatic activity of RET G810S in an in vitro assay and inhibited proliferation of cells expressing RET G810S in culture (J Clin Oncol 40, no. 16_suppl (June 1, 2022)). | detail... |
RET G810S | Advanced Solid Tumor | predicted - sensitive | TY-1091 | Preclinical - Cell culture | Actionable | In a preclinical study, TY-1091 inhibited activity in a cell line expressing RET G810S in culture (Cancer Res (2023) 83 (7_Supplement): 3419). | detail... |